Sigumir is a peptide bioregulator specifically harnessed to boost and protect the function of the cartilage.
Benefits of Sigumir peptide bioregulator
Helps restore cartilage and bone function, preventing painful posture- and joint-disorders
Provides protection from arthritis, osteoporosis, gout, and more
Particularly valuable for those of advanced age, who are more susceptible to joint and spine conditions
Serves the same role as peptide bioregulators developed naturally in the body
No adverse side effects
The importance of optimum cartilage function
Cartilage is the inelastic tissue that allows for full and easy movement of joints, preventing bones from rubbing together. As we age, cartilage can become weak and ineffective. This leads to all types of painful and debilitating conditions such as rheumatism, arthritis, and posture deformities.
By regulating specific cell development, Sigumir ensures that cartilage remains firm and healthy long after lifestyle-induced wear and tear would have naturally compromised the tissue.
What is a peptide bioregulator
peptide is a short chain of amino acids, identified by the fact that it is shorter than a protein, and so can be absorbed easily via the digestive system. Each organ or bodily function has its own unique peptide bioregulator.
Peptide bioregulators have been shown to shortcut the protein synthesis process by interacting directly with cell DNA – meaning that organs can build and repair tissues easier and quicker when peptide bioregulators are active.
Professor Vladimir Khavinson’s approach to aging
Peptide bioregulators were first discovered in the 1980s by professor Vladimir Khavinson, a doctor working on behalf of the Kremlin to devise palliative care medicines for army veterans.
He noticed that in healthy individuals with all their bodily faculties working at optimum performance, the level of peptide bioregulators in each of their organs was exactly 42%.
New Russian peptide revolution
Decades of testing fostered a 'new Russian peptide revolution', as it was revealed that supplementing peptide bioregulators with synthetically created natural analogues yielded no adverse side effects, yet served the same role as those developed organically in the body, which decrease as we age. Hence, a remarkable new range of supplements has entered the market.